Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Jan 12, 2007 10:13am
180 Views
Post# 12004366

RE: Like Riti said Even the I.N.T. could be 2 ...

RE: Like Riti said Even the I.N.T. could be 2 ... No i haven't contacted them re: HepC final.......but if E1-INT is required to be released in a timely manner then why shouldn't all other trials be held to the same standard. Bit of a tug'o'war .....who'll fold first? I say yhme......lol "NO DEAL" I CAN HEAR HIM SAY!!!!!
Bullboard Posts